Department of Urology, Nanchong Central Hospital, The Second Clinical College, North Sichuan Medical College (University), Nanchong, 63700, Sichuan, China.
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Int J Surg. 2022 Sep;105:106853. doi: 10.1016/j.ijsu.2022.106853. Epub 2022 Sep 6.
To compare the safety and effectiveness of robot-assisted adrenalectomy (RA) and laparoscopic adrenalectomy (LA).
We performed a systematic review and cumulative meta-analysis of the primary outcomes of interest according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR (Assessing the Methodological Quality of Systematic Reviews) Guidelines. Five databases, including Medline, PubMed, Cochrane Library, Scopus, and Web of Science, were systematically searched. The search timeframe was set from the creation of the database to December 2021.
There were 26 studies including 2985 patients. Our study found that the robotic technique was superior to conventional laparoscopy for estimated blood loss (WMD = -18.25, 95% CI [-27.85, -8.65], P < 0.01), length of stay (WMD = -0.45, 95% CI [-0.57, -0.33], P < 0.01), and conversion to open (OR = 0.31, 95% CI [0.12, 0.78], P = 0.01), while complications and readmissions were comparable. Interestingly, there was no difference in operative time between the two surgical modalities, but subgroup analysis found that the retroperitoneal route robotic technique took longer (WMD = 14.64, 95% CI [0.04, 29.24], P < 0.05), whereas the study of the mixed surgical modality (RA versus LA with mixed transabdominal and retroperitoneal surgical routes) found that the robot required less time (WMD = -12.29, 95% CI [-22.86, -1.72], P < 0.05). For pheochromocytoma, RA was superior to LA in terms of length of stay (WMD = -0.49, 95% CI [-0.83, -0.15], P < 0.01), with no difference in other indicators.
robotic-assisted adrenalectomy is a superior technique to conventional laparoscopy in managing adrenal tumors, even in the case of a specific adrenal tumor - pheochromocytoma.
比较机器人辅助肾上腺切除术(RA)和腹腔镜肾上腺切除术(LA)的安全性和有效性。
我们根据 PRISMA(系统评价和荟萃分析的首选报告项目)和 AMSTAR(系统评价方法学质量评估)指南,对主要感兴趣的结局进行了系统评价和累积荟萃分析。我们系统地检索了包括 Medline、PubMed、Cochrane 图书馆、Scopus 和 Web of Science 在内的五个数据库。搜索时间范围设定为数据库创建到 2021 年 12 月。
共有 26 项研究纳入 2985 名患者。我们的研究发现,机器人技术在估计失血量(WMD=-18.25,95%CI[-27.85,-8.65],P<0.01)、住院时间(WMD=-0.45,95%CI[-0.57,-0.33],P<0.01)和中转开放手术(OR=0.31,95%CI[0.12,0.78],P=0.01)方面优于传统腹腔镜,而并发症和再入院率则相似。有趣的是,两种手术方式的手术时间无差异,但亚组分析发现后腹腔入路机器人技术时间更长(WMD=14.64,95%CI[0.04,29.24],P<0.05),而混合手术模式的研究(机器人辅助肾上腺切除术与混合经腹和后腹腔手术途径的腹腔镜肾上腺切除术)发现机器人手术时间更短(WMD=-12.29,95%CI[-22.86,-1.72],P<0.05)。对于嗜铬细胞瘤,RA 在住院时间方面优于 LA(WMD=-0.49,95%CI[-0.83,-0.15],P<0.01),其他指标无差异。
机器人辅助肾上腺切除术在处理肾上腺肿瘤方面优于传统腹腔镜,即使是特定的肾上腺肿瘤——嗜铬细胞瘤也是如此。